FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

Teclistamab for RRMM: Long term follow up data from MajesTEC-1

2L triple metronomic chemo shows more efficacy in comparison to systemic therapy for head and neck cancer

Vaccine-immunotherapy combo for high risk melanoma: New data on distant metastasis-free survival

Next-generation selective RET inhibitor shows initial promise with RET-altered solid tumours

Trastuzumab deruxtecan gives strong anti-tumour activity and durable responses in multiple tumour types

Neoadjuvant chemo with mFOLFIRINOX shows survival benefit in locally advanced rectal cancer

PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo

Osimertinib after surgery significantly improves survival in resected EGFR-mutated NSCLC

ASCO 2023: Breast cancer research highlights

Ciltacabtagene autoleucel greatly reduces risk of disease progression in lenalidomide-refractory MM

mRCC: Atezolizumab after progression with prior ICI treatment shows no benefit and increases toxicity